Exact Therapeutics AS
Not financial advice. The index, rank, signals and advice are rule-based indications from the latest filed annual accounts. They are not a credit rating, an assessment of management or a recommendation to buy, sell or do business with the company. Read more
Score · fiscal year 2025
Not enough data: Not enough data (below minimum revenue)
Based on the annual accounts for 2025
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 0 MNOK | 3 MNOK |
| Operating margin | −143,338.1% | 5.5% |
| Profit margin | −146,819.2% | 5.2% |
| Return on assets | −120.8% | 10.8% |
| Equity ratio | 66.7% | 41.9% |
| Debt-to-equity | 0.50 | 1.09 |
| Current ratio | 2.78 | 1.68 |
| Revenue growth | – | 6.0% |
| Revenue per employee | 0.00 MNOK | 0.85 MNOK |
The median and “ahead of” refer to companies in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
Score over time
Score over time needs at least two fiscal years with a score. It will appear when next year's figures are fetched or history is imported.
The industry or the company: what drove the result?
The company and its sector's drivers
Prices, rate and currency that shape the sector's year, year by year beside the operating margin of Exact Therapeutics AS. The figures stand side by side; we claim no cause.
Turnover index: architectural and engineering activities (indeks (2021 = 100))
| Measure | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Turnover index: architectural and engineering activities, annual average | 99.0 | 108.8 | 127.9 | 146.4 | 158.3 | 155.2 (so far) |
| Change from the year before | +9.8% | +9.9% | +17.5% | +14.5% | +8.1% | −1.9% |
| The company's operating margin | – | – | −1,074,927.0% | – | −143,338.1% | – |
Source: SSB (13863, CC BY 4.0). Source
Turnover index: advertising and market research (indeks (2021 = 100))
| Measure | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Turnover index: advertising and market research, annual average | 99.4 | 113.5 | 108.3 | 106.9 | 110.7 | 126.1 (so far) |
| Change from the year before | +35.1% | +14.2% | −4.6% | −1.3% | +3.6% | +13.9% |
| The company's operating margin | – | – | −1,074,927.0% | – | −143,338.1% | – |
Source: SSB (13863, CC BY 4.0). Source
Turnover index: other professional and technical activities (indeks (2021 = 100))
| Measure | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Turnover index: other professional and technical activities, annual average | 98.3 | 121.6 | 139.4 | 131.0 | 139.1 | 158.0 (so far) |
| Change from the year before | +29.9% | +23.7% | +14.6% | −6.0% | +6.2% | +13.6% |
| The company's operating margin | – | – | −1,074,927.0% | – | −143,338.1% | – |
Source: SSB (13863, CC BY 4.0). Source
Service prices: architects and engineering (indeks (2021 = 100))
| Measure | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Service prices: architects and engineering, annual average | 100.0 | 103.6 | 107.5 | 111.2 | 114.7 | 119.4 (so far) |
| Change from the year before | +1.2% | +3.5% | +3.8% | +3.4% | +3.2% | +4.2% |
| The company's operating margin | – | – | −1,074,927.0% | – | −143,338.1% | – |
Source: SSB (14335, CC BY 4.0). Source
Oil price (export price of crude oil) (kr per fat)
| Measure | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Oil price (export price of crude oil), annual average | 609 | 979 | 877 | 859 | 708 | 881 (so far) |
| Change from the year before | +61.1% | +60.8% | −10.5% | −2.0% | −17.6% | +24.5% |
| The company's operating margin | – | – | −1,074,927.0% | – | −143,338.1% | – |
Source: SSB (08799, CC BY 4.0). Source
Policy rate (prosent)
| Measure | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Policy rate, annual average | 0.08 | 1.32 | 3.54 | 4.50 | 4.30 | 4.17 (so far) |
| Change from the year before | −0.28 percentage points | +1.24 percentage points | +2.22 percentage points | +0.96 percentage points | −0.20 percentage points | −0.12 percentage points |
| The company's operating margin | – | – | −1,074,927.0% | – | −143,338.1% | – |
Source: Norges Bank (IR, NLOD 2.0). Source
EUR/NOK (kr)
| Measure | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| EUR/NOK, annual average | 10.16 | 10.10 | 11.42 | 11.62 | 11.72 | 11.04 (so far) |
| Change from the year before | −5.2% | −0.6% | +13.1% | +1.8% | +0.8% | −5.8% |
| The company's operating margin | – | – | −1,074,927.0% | – | −143,338.1% | – |
Source: Norges Bank (EXR, NLOD 2.0). Source
Wage index: architects and engineering (indeks)
| Measure | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Wage index: architects and engineering, annual average | 90.5 | 90.9 | 96.0 | 100.9 | 105.6 | 109.2 (so far) |
| Change from the year before | +7.4% | +0.5% | +5.6% | +5.2% | +4.7% | +3.4% |
| The company's operating margin | – | – | −1,074,927.0% | – | −143,338.1% | – |
Source: SSB (12314, CC BY 4.0). Source
We show the drivers and the margin side by side and claim no cause. Sensitivity per company is not computed until we have at least 10 years of accounts per company: with three years such figures are false precision.
What the numbers say
Exact Therapeutics AS had an equity ratio of 66.7% in 2025. The company is not ranked: not enough data (below minimum revenue).
From 2024 to 2025: the equity ratio fell from 85.0% to 66.7%.
This text is generated automatically from the 2025 accounts.
Three simple methods
One method gives a figure: 96 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 18.6 | not meaningful |
| EV/EBIT | 15.9 | not meaningful |
| P/B | 3.2 | 96 MNOK |
The listed basis is the value at listed multiples. The estimate is lowered for size: a small-company premium of 3% on the cost of equity gives a value 32% lower. No separate marketability discount is applied, because the premium already allows for the company being small and unlisted.
The NACE code has no listed industry of its own in the table, so the multiples are the sector median: Engineering/Construction, Business & Consumer Services.
Not financial advice. The value range is a rough model estimate from listed-company multiples, not a valuation, a price target or a price offer. The actual value may differ greatly. Read more
A mechanical estimate from public accounts, not advice. A mechanical estimate from public accounts with listed multiples and fixed adjustments. Not a valuation and not advice to buy or sell. See the calculation
Worth a closer look
- watch
The company made a loss before tax. Are these one-off items or a pattern?
Based on: Profit margin −146,819.2% (median 5.2%).
- watch
The operating margin is lower than at three in four companies in the sector. Where do costs differ from competitors?
Based on: Operating margin −143,338.1% (median 5.5%).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 30.7% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
- watch Extreme margin: check the figures
Scenario analysis: the sector's weakest year
We have no accounts for 2021, the sector's weakest year, for this company.
The sector's weakest year was 2021, with a median operating margin of −0.2%. Based on the 8 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
Questions and answers
How profitable is Exact Therapeutics AS?
The operating margin was −143,338.1% in 2025, against a median of 5.5% among companies in the same sector. Return on assets was −120.8%. The company made a loss before tax.
How solid is Exact Therapeutics AS?
The equity ratio was 66.7% in 2025 (median 41.9%). Debt-to-equity was 0.50 (median 1.09).
What is the liquidity of Exact Therapeutics AS like?
The current ratio was 2.78 in 2025 (median 1.68).
Group accounts · 2025
18 of 100
Rank 81 of 88 groups in Teknisk tjenesteyting og forskning. Groups are ranked only against other groups in the same sector, never against single companies.
- Operating revenue, group
- 0 MNOK
- Operating profit, group
- −85 MNOK
- Profit before tax, group
- −87 MNOK
- Total assets, group
- 67 MNOK
- Equity, group
- 31 MNOK
| Key figure | The group | The company alone (2025) |
|---|---|---|
| Operating margin | −143,859.9% | −143,338.1% |
| Return on assets | −119.0% | −120.8% |
| Equity ratio | 45.6% | 66.7% |
| Current ratio | 1.65 | 2.78 |
| Revenue growth | – | – |
Group index in earlier years: 2023: 33 (82 of 101), 2024: 29 (73 of 90).
Same formulas and weights as the company index. Group and company are never added together, and the group accounts are not part of sector averages or company rankings.
Source: Brønnøysund Register Centre, group accounts 2025 (open data, NLOD 2.0).
The shareholder register shows no Norwegian majority owner and no subsidiaries for this company.
From the Central Coordinating Register
- Org. no.
- 998317487
- Legal form
- AS
- Sector
- Teknisk tjenesteyting og forskning (72.100)
- Morning company class
- Micro
- Employees
- 12 registered 10 May 2026
- Founded
- 12 April 2012 14 years in operation
- Share capital
- 0.45 MNOK
- Business address
- Sognsveien 72, 0855 OSLO
- Municipality
- Oslo rank 63–220 of 357 in Norway
- Latest accounts filed
- 2025
- LEI
- 2138006ZE5JAL39AGD55 renews 29 September 2027
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
Loading roles …
Source: Central Coordinating Register, fetched 1 November 2026. Only names are shown.
- Parent company
- No parent company: owned by persons
Source: GLEIF (Global Legal Entity Identifier Foundation), fetched 30 October 2026. The parent is the one the company itself reported to GLEIF.
Shareholders (2025)
- Number of shareholders
- 377
- Largest owner
- 26.3% · top three 42.7%
- Split
- companies 88% · private persons 12% · foreign 33%
- Owned from the same municipality
- 59%
- Owners over 60
- 85% of the shares held by persons (median age 62)
- Ubs Financial Services INC. (USA) · 26.3%
- Investinor Direkte AS · 9.7%
- Canica AS · 6.8%
- Brekke Holding AS · 4.8%
- Kvåle AS · 4.8%
- Paacs Invest AS · 4.3%
- Helene Sundt AS · 4.2%
- Optimuspistor AS · 2.8%
- GOLDMAN SACHS & CO. LLC (USA) · 2.0%
- J.P. Morgan SE (Luxembourg) · 2.0%
- 276 private persons · 11.6%
The company is new in the shareholder register in 2025.
Source: the Norwegian Tax Administration's shareholder register as of 2025. Figures may be older than today's ownership. Private persons are not shown by name.
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Is this your company? Suggest changes or add information
Figures last fetched 5 November 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | – | – | – | |
| Rank | – | – | – | |
| Operating margin | −1,074,927.0% | – | −143,338.1% | |
| Return on assets | −80.7% | −33.7% | −120.8% | |
| Equity ratio | 72.7% | 85.0% | 66.7% | |
| Current ratio | 3.50 | 5.85 | 2.78 | |
| Revenue growth | – | – | – |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 0.0 MNOK | – | 0.1 MNOK |
| Operating profit | −47.9 MNOK | −52.2 MNOK | −84.6 MNOK |
| Profit before tax | −48.1 MNOK | −51.6 MNOK | −86.6 MNOK |
| Tax expense | – | – | – |
| Net profit | −48.1 MNOK | −51.6 MNOK | −86.6 MNOK |
| Financial expenses | 1.2 MNOK | 0.6 MNOK | 6.8 MNOK |
| Total assets | 58.1 MNOK | 151.2 MNOK | 66.1 MNOK |
| Current assets | 55.5 MNOK | 133.1 MNOK | 61.1 MNOK |
| Equity | 42.3 MNOK | 128.4 MNOK | 44.1 MNOK |
| Retained earnings | – | – | – |
| Total liabilities | 15.8 MNOK | 22.8 MNOK | 22.0 MNOK |
| Current liabilities | 15.8 MNOK | 22.8 MNOK | 22.0 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 5 November 2026, accounts id 7234376.